Table 1 Clinical findings of 14 patients with concurrent t(14;18) and 8q24/c-MYC rearrangement
Case | A/G | BM | CSF | Extramedullary sites | Therapy | Follow-up (mo) | Histology |
|---|---|---|---|---|---|---|---|
1 | 54/F | − | − | Small intestine | C | A (7) | DLBCL |
2 | 54/M | − | − | Lung, chest wall, testis | C | D (10) | DLBCL |
3 | 64/M | + | + | — | C | D (81) | DLBCL |
4 | 29/M | + | − | — | C | D (5) | BL |
5 | 72/M | + | − | — | C | A (11) | BL |
6 | 50/F | + | + | — | C | D (3) | BL |
7 | 32/M | + | + | Mesenteric LN | C | D (8) | BL |
8 | 67/M | + | −/+ | Pelvic LN, small intestine | C | D (9) | BLL |
9 | 61/M | + | −/+ | Retroperitoneal LN, colon, prostate | C | D (9) | BLL |
10 | 42/F | + | − | Small intestine, omentum, breast | C, BMT, RT | D (12) | BLL |
11 | 63/M | + | − | Testis, lip | C | D (18) | BLL |
12 | 55/M | − | − | Ileocecal valve | C | A (5) | BLL |
13 | 58/M | + | − | Retroperitoneal LN | C, BMT | D (8) | PCM |
14 | 32/F | + | − | — | Rituximab | A (7) | Low-grade BCL |
